Blog

28 February 2026

February 2026 Dermatology Update: Key FDA Approvals and Treatments

Stay updated with the February 2026 Dermatology Update, featuring key FDA approvals, including Galderma's relabotulinumtoxinA for wrinkles and AbbVie's vitiligo...
Read more
February 2026 Dermatology Update: Key FDA Approvals and Treatments
Enhancing Biologic Treatment Strategies for Hidradenitis Suppurativa

Enhancing Biologic Treatment Strategies for Hidradenitis Suppurativa

Discover innovative biologic treatment strategies for Hidradenitis Suppurativa, addressing complex patient needs and improving long-term outcomes in dermatology.
1 03 2026
Read more
Abrocitinib Offers Rapid Relief for Patients with Itch-Dominant AD

Abrocitinib Offers Rapid Relief for Patients with Itch-Dominant AD

Discover how abrocitinib provides rapid relief for patients with itch-dominant atopic dermatitis, improving quality of life in this crucial analysis.
25 02 2026
Read more
Understanding the Long-Term Challenges of Hidradenitis Suppurativa

Understanding the Long-Term Challenges of Hidradenitis Suppurativa

Discover the long-term challenges of hidradenitis suppurativa (HS) from expert Thrasyvoulos Tzellos, MD. Learn about its progressive nature and patient...
25 02 2026
Read more
Remibrutinib Achieves Key Milestone in Phase 3 Trial for CIndU

Remibrutinib Achieves Key Milestone in Phase 3 Trial for CIndU

Discover how remibrutinib achieved a key milestone in its phase 3 trial for chronic inducible urticaria (CIndU), setting the stage...
24 02 2026
Read more
Revolutionizing Acne Treatment: Denifanstat Targets Sebum Production

Revolutionizing Acne Treatment: Denifanstat Targets Sebum Production

Discover how denifanstat is revolutionizing acne treatment by targeting sebum production. Learn about this innovative therapy that offers a new...
23 02 2026
Read more
Alphyn Biologics Launches Phase 2 Trial for Zabalafin Hydrogel Treatment

Alphyn Biologics Launches Phase 2 Trial for Zabalafin Hydrogel Treatment

Alphyn Biologics announces a Phase 2 trial for Zabalafin Hydrogel, targeting molluscum contagiosum in pediatric patients. Discover this innovative treatment's...
23 02 2026
Read more
Brepocitinib Shows Promising Phase 2 Results for Rare Skin Disease

Brepocitinib Shows Promising Phase 2 Results for Rare Skin Disease

Discover the promising Phase 2 results of brepocitinib for cutaneous sarcoidosis, showcasing impressive efficacy and safety in a rare skin...
23 02 2026
Read more
Navigating Systemic Mastocytosis: A Patient’s Journey to Diagnosis and Care

Navigating Systemic Mastocytosis: A Patient’s Journey to Diagnosis and Care

Discover Suki Tipp's journey through systemic mastocytosis, from misdiagnosis to effective care. Learn the importance of early recognition in this...
22 02 2026
Read more